戻る Agenda
Session 27: Benefit-Risk Management
Session Chair(s)
Jill W. Buckley, PHARMD
Adjunct Assistant Professor
Rutgers, the State University of New Jersey, United States
The session will provide an introduction to benefit-risk assessment, with a focus on formal post-marketing risk management, primarily in the US and EU context. This session will encompass post-marketing risk assessment, Risk Management Plans (RMPs), and Risk Evaluation and Mitigation Strategies (REMS).